Member Info for SYN00GOLD

I think we will hear about another offer in the next couple of weeks. Watch the price explosion then !

Facts are facts and an offer was made of £1.70p per share.

Another simple fact is that this is a massive growth trajectory company that will only get stronger through these turbulent times. Ignore the week to week games and nonsense. This share WILL be minimum of £3 by summer of 2023 :-)

Enjoy the lovely weather and log off !!

Yup, nice 1.5 million buy to close out UT :-)

I'm still so far down its funny....................come on £2.50 !!!

A pessimist will see Difficulty in every opportunity whereas an optimist will see opportunity every difficult situation - Winston Churchill

Let’s hope new trials will accurately target endpoints and prove the drug’s effectiveness. I still believe

https://twitter.com/MartinLandray/status/1536014189893926914

Let us hope Buzz has been chatting re-respiratory infections and trials in general !!!!

'at haste' = working towards an 'imminent' announcement :-)

https://www.londonstockexchange.com/news-article/GSK/gsk-to-acquire-affinivax-inc/15475343

Just a quick purchase for 2.1 Billion, having never done more than a phase 2. The big boys will conduct the phase 3 soon.

Bought lock, stock and barrel !!

Our time will come :-)

wpa5- could not have said it any better. I truly believe this will get to commercialisation, I will remain in a zen like patience.

Wishing all a healthy and relaxed weekend.

...........I find myself trading which I never did in past, whilst retaining my original shares holding. Will now wait for next spike ......sigh :-(

No

SNG001 has a place in the market, however, I do not anticipate any solid/meaningful results this year. I am storing my shares under the bed in storage. Glad I bought more when in low 20s and taken a decent return to recoup some losses.
My hope is RM is having serious discussions with PT leaders and NIH in USA..................................but who knows !!!

Hope you are keeping well Sparkyboy - A lot of us are sitting here in the background :-)

I was really impressed with RM's proactive interview and the results of the deepdive data. Hoping that the team can now get very focussed, specific endpoint and smash the next trial, be that via JV/TO/PT/A2 !!

Definitely a gargantuan market out there for a viral agnostic drug that directly targets lungs. Although battered and bruised, I am keeping my shares and have accumulated a fair few since THAT day in Feb !!!!!

Good luck all.................................HOLD from me :-)

I'll eat Buzz Marsden's shorts if he pulls a rabbit out of the bag !!!

The study’s chief investigator as well as a professor of respiratory medicine at the University of Southampton, Tom Wilkinson, commented on the updated deep dive analysis results.

“The improvement in standard of care for COVID-19 means that most patients are currently discharged fairly rapidly from hospital; however, this further analysis shows that some patients struggle in their battle with the virus and show signs of respiratory compromise, with faster breathing rates and lower oxygen saturations, despite being on oxygen. For these higher-risk patients, there remains an urgent need for new treatment options, and this analysis suggests that SNG001 could be a potentially efficacious treatment option for them.”

Let's hope the team convert talking into action. TBH, I would not mind a fund raise and doubling the volume of shares to 400 million,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IF, the funded trial was highly focussed and specific, and conducted NOW in North Korea :-)

The SP on successful outcome would hit £10 easily, the drug would sell itself from then on....................

Agree Tommy - Trial was not managed appropriately unfortunately, however the drug DOES work :-)

ACTIV-2 NIH progressed automatically to P3 status. The story is far far from over.

Excellent and ................today announces the first presentation of the full data analysis from its Phase 3 SPRINTER trial evaluating the efficacy and safety of SNG001 in patients hospitalised with COVID-19.

Just the FIRST = more to follow !!

Well said Tommy. I am prepared for all scenarios now. However, I do still have total belief that eventually SNG001 will be in hospitals worldwide and save lives in future pandemics and find it’s niche in many respiratory conditions.

Plagiarised from very British problems, but hit a chord with my pain from 21 Feb 2022:
Synairgen LTH's, inches from the abyss, with no way back, only eternal nothingness in front of them and thousands of broken dreams and lost hopes lying shattered and scattered behind, will consider the situation, let out a deep sigh and utter their final words:

“Could be worse”

I remain a LTH, wishing all good health.

https://www.bbc.co.uk/news/health-61327778

Hi Woody,
At some stage cash will become a factor obviously. Without any trial costs, current costs are ‘limited’, so I think there is plenty of cash. Let us hope that platform’s are an avenue:-)

Good to see you online. Lot of us are still here in the background. I still believe that despite everything SNG001 will eventually become a commercial product. Respiratory conditions will always be with us and so will viruses and long covid. As you have said, sometimes Pharma play dirty, and non are immune from shenanigans.

Another great book is 'Empire of Pain'. Enough said about the biggest Pharmaceutical Company in history.

Our time will come. I think support is needed from Pharma in all likelihood, knowing the 'dark arts' at play.

Keep safe and good health to all LTH :-)